Naturalendo Tech Co Ltd (168330) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Naturalendo Tech Co Ltd (168330) has a cash flow conversion efficiency ratio of -0.039x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-882.79 Million ≈ $-598.25K USD) by net assets (₩22.92 Billion ≈ $15.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Naturalendo Tech Co Ltd market capitalisation for the company's overall valuation and market capitalisation.
Naturalendo Tech Co Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Naturalendo Tech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Naturalendo Tech Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Naturalendo Tech Co Ltd ranked by their cash flow conversion efficiency. Explore 168330 cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lion One Metals Limited
V:LIO
|
-0.011x |
|
Zegona Communications Plc
LSE:ZEG
|
-0.535x |
|
Vanet Gida Sanayi Ic ve Dis Ticaret AS
IS:VANGD
|
-0.049x |
|
Alpha Holdings Inc
KQ:117670
|
-0.065x |
|
Cords Cable Industries Limited
NSE:CORDSCABLE
|
0.132x |
|
Doxa AB
ST:DOXA
|
0.055x |
|
Gmb Korea
KO:013870
|
0.023x |
|
International Meal Company Alimentação S.A
SA:MEAL3
|
0.037x |
Annual Cash Flow Conversion Efficiency for Naturalendo Tech Co Ltd (2014–2025)
The table below shows the annual cash flow conversion efficiency of Naturalendo Tech Co Ltd from 2014 to 2025. View 168330 stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩23.25 Billion ≈ $15.75 Million |
₩-5.66 Billion ≈ $-3.84 Million |
-0.243x | -206.18% |
| 2024-12-31 | ₩26.87 Billion ≈ $18.21 Million |
₩-2.14 Billion ≈ $-1.45 Million |
-0.080x | +27.90% |
| 2023-12-31 | ₩30.94 Billion ≈ $20.97 Million |
₩-3.41 Billion ≈ $-2.31 Million |
-0.110x | +11.18% |
| 2022-12-31 | ₩36.58 Billion ≈ $24.79 Million |
₩-4.54 Billion ≈ $-3.08 Million |
-0.124x | +44.42% |
| 2018-12-31 | ₩36.49 Billion ≈ $24.73 Million |
₩-8.15 Billion ≈ $-5.52 Million |
-0.223x | -62.67% |
| 2017-12-31 | ₩54.72 Billion ≈ $37.08 Million |
₩-7.52 Billion ≈ $-5.09 Million |
-0.137x | +64.47% |
| 2016-12-31 | ₩47.30 Billion ≈ $32.05 Million |
₩-18.28 Billion ≈ $-12.39 Million |
-0.387x | -165.39% |
| 2015-12-31 | ₩50.46 Billion ≈ $34.20 Million |
₩-7.35 Billion ≈ $-4.98 Million |
-0.146x | -200.14% |
| 2014-12-31 | ₩71.65 Billion ≈ $48.55 Million |
₩10.42 Billion ≈ $7.06 Million |
0.145x | -- |
About Naturalendo Tech Co Ltd
Naturalendo Tech Co., Ltd. engages in the research, development, manufacture, and sale of natural product new drugs, cosmetics, materials, food additives, and health functional food in South Korea. The company offers EstroG-100, a functional raw material for women's menopause; HabaNova, a diet material; YGF 251, a phyto height growth booster; NET 2401, a multiway sleep-wake cycle regulator; Staun… Read more